Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials

BACKGROUND: The prospect for targeted therapies in advanced hepatocellular carcinoma (HCC) has dramatically changed since several recent clinical trials have yielded promising results. The number of second-line therapies is increasing, though the consequent challenge is to consider differences betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dongxu, Yang, Xu, Lin, Jianzhen, Bai, Yi, Long, Junyu, Yang, Xiaobo, Seery, Samuel, Zhao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Diagnosis, Management, and Prognostic Assessment of Liver Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313339/
https://www.ncbi.nlm.nih.gov/pubmed/32636928
http://dx.doi.org/10.1177/1756284820932483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313339/
https://www.ncbi.nlm.nih.gov/pubmed/32636928
http://dx.doi.org/10.1177/1756284820932483

Ejemplares similares